BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 238 filers reported holding BLUEPRINT MEDICINES CORP in Q3 2022. The put-call ratio across all filers is 0.57 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $328,794 | -39.3% | 7,505 | -8.8% | 0.00% | -50.0% |
| Q3 2022 | $542,000 | +30.6% | 8,227 | +0.2% | 0.01% | +33.3% |
| Q2 2022 | $415,000 | -21.0% | 8,210 | 0.0% | 0.01% | -14.3% |
| Q1 2022 | $525,000 | -40.3% | 8,210 | -0.1% | 0.01% | -50.0% |
| Q4 2021 | $880,000 | +4.3% | 8,219 | +0.1% | 0.01% | +27.3% |
| Q3 2021 | $844,000 | +3.2% | 8,212 | -11.7% | 0.01% | +10.0% |
| Q2 2021 | $818,000 | -2.0% | 9,300 | +8.3% | 0.01% | -16.7% |
| Q1 2021 | $835,000 | -0.7% | 8,589 | +14.5% | 0.01% | 0.0% |
| Q4 2020 | $841,000 | +21.0% | 7,500 | 0.0% | 0.01% | +9.1% |
| Q3 2020 | $695,000 | – | 7,500 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 716,539 | $36,192,000 | 12.35% |
| CADIAN CAPITAL MANAGEMENT, LP | 2,020,629 | $102,062,000 | 6.89% |
| Casdin Capital, LLC | 1,150,000 | $58,087,000 | 4.91% |
| DAFNA Capital Management LLC | 261,280 | $13,197,000 | 3.60% |
| Nextech Invest Ltd. | 188,228 | $9,507,000 | 3.21% |
| Eagle Health Investments LP | 170,551 | $8,615,000 | 2.01% |
| Boxer Capital, LLC | 507,374 | $25,627,000 | 1.62% |
| Rock Springs Capital Management LP | 979,174 | $49,458,000 | 1.44% |
| EFG Asset Management (North America) Corp. | 130,454 | $6,589,000 | 1.39% |
| Integral Health Asset Management, LLC | 130,000 | $6,566,000 | 1.35% |